Completed
An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or Has Spread - CA209-142
Aggiornato:
21 ottobre, 2025
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice